Clinical trial
Simplified Geriatric Assessment-Based Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer: Protocol for a Prospective Multicenter Cohort Study (SGA-OCRC)
NCT07903129 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started June 2027. Observational study, 1,000 participants (estimated). Lead sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine. Primary measure: 90-day major adverse postoperative outcomes (MAPO).
How it compares
1,394 similar trials: same condition (Colorectal Neoplasms) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Simplified Geriatric Assessment-Based Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer: Protocol for a Prospective Multicenter Cohort Study (SGA-OCRC)
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 30, 2027
- Completion date
- September 30, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
MeSH condition names; the registry's own terms follow.
Colorectal Neoplasms, Postoperative Complications
Registry terms: octogenarian patients with non-metastatic resectable colorectal cancer
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 80 Years
- Healthy volunteers
- No
- Study type
- Observational
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| Surgical Cohort | ||
Show registry wordingPatients who undergo curative-intent colorectal resection will form the primary analysis cohort | ||
| Non-surgical Cohort | ||
Show registry wordingPatients who fail to receive surgical resection will form the primary analysis cohort | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| 90-day major adverse postoperative outcomes (MAPO) | 90 days after surgery |
Show registry wordingThe primary outcome is 90-day major adverse postoperative outcomes (MAPO), defined as the occurrence of any of the following: 1. Clavien-Dindo grade ≥III complication: a postoperative complication requiring surgical, endoscopic, or radiological intervention, or more intensive treatment for life-threatening complications.
The primary composite outcome will be analyzed as a binary variable. Patients will be classified as having MAPO if at least one qualifying event occurs within 90 days after surgery. | |
Lead sponsor's other trials
Second Affiliated Hospital, Zhejiang University, School of Medicine, most recent start first.
+1,141 more trials
Similar trials
Same condition (Colorectal Neoplasms) and phase, most recent start first.
+1,389 more trials See the condition page